{
  "resourceType" : "ValueSet",
  "id" : "2.16.840.1.113762.1.4.1116.174",
  "meta" : {
    "versionId" : "3",
    "lastUpdated" : "2023-04-03T13:49:33.000-04:00",
    "profile" : ["http://hl7.org/fhir/StructureDefinition/shareablevalueset",
    "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"]
  },
  "extension" : [{
    "url" : "http://hl7.org/fhir/StructureDefinition/valueset-author",
    "valueString" : "CancerLinQ Author"
  },
  {
    "url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
    "valueDate" : "2022-12-15"
  },
  {
    "url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
    "valueDate" : "2023-04-03"
  }],
  "url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.174",
  "identifier" : [{
    "system" : "urn:ietf:rfc:3986",
    "value" : "urn:oid:2.16.840.1.113762.1.4.1116.174"
  }],
  "version" : "20150910",
  "name" : "Gefitinib",
  "title" : "Gefitinib",
  "status" : "active",
  "experimental" : false,
  "date" : "2015-09-10T01:00:03-04:00",
  "publisher" : "CancerLinQ Steward",
  "jurisdiction" : [{
    "extension" : [{
      "url" : "http://hl7.org/fhir/StructureDefinition/data-absent-reason",
      "valueString" : "UNKNOWN"
    }]
  }],
  "purpose" : "(Clinical Focus: ),(Data Element Scope: ),(Inclusion Criteria: ),(Exclusion Criteria: )",
  "compose" : {
    "include" : [{
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "concept" : [{
        "code" : "349472",
        "display" : "gefitinib 250 MG Oral Tablet"
      },
      {
        "code" : "358777",
        "display" : "gefitinib 250 MG"
      },
      {
        "code" : "378629",
        "display" : "gefitinib Oral Tablet"
      },
      {
        "code" : "402091",
        "display" : "gefitinib 250 MG Oral Tablet [Iressa]"
      },
      {
        "code" : "402435",
        "display" : "gefitinib Oral Tablet [Iressa]"
      },
      {
        "code" : "576099",
        "display" : "gefitinib 250 MG [Iressa]"
      }]
    }]
  },
  "expansion" : {
    "identifier" : "urn:uuid:2dd3f03e-aa8d-421c-ab34-9eeaf528009e",
    "timestamp" : "2023-09-26T10:35:41-04:00",
    "total" : 6,
    "offset" : 0,
    "parameter" : [{
      "name" : "count",
      "valueInteger" : 1000
    },
    {
      "name" : "offset",
      "valueInteger" : 0
    }],
    "contains" : [{
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version" : "09052023",
      "code" : "349472",
      "display" : "gefitinib 250 MG Oral Tablet"
    },
    {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version" : "09052023",
      "code" : "358777",
      "display" : "gefitinib 250 MG"
    },
    {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version" : "09052023",
      "code" : "378629",
      "display" : "gefitinib Oral Tablet"
    },
    {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version" : "09052023",
      "code" : "402091",
      "display" : "gefitinib 250 MG Oral Tablet [Iressa]"
    },
    {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version" : "09052023",
      "code" : "402435",
      "display" : "gefitinib Oral Tablet [Iressa]"
    },
    {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version" : "09052023",
      "code" : "576099",
      "display" : "gefitinib 250 MG [Iressa]"
    }]
  }
}